-
公开(公告)号:US20220356225A1
公开(公告)日:2022-11-10
申请号:US17763122
申请日:2020-09-23
发明人: Kole T. ROYBAL , Iowis ZHU , Raymond LIU , Ahmad S. KHALIL , Divya ISRANI
IPC分类号: C07K14/705 , C07K16/28 , C07K14/725 , A61K35/17 , C12N5/0783
摘要: The present disclosure generally relates to, inter alia, a new class of chimeric Notch receptors containing a synthetic zinc finger transcriptional effector (synZTE) module, engineered to modulate gene expression and cellular activities in a ligand-dependent manner. The new Notch receptors surprisingly retain the ability to transduce signals in response to ligand binding despite that the Notch extracellular subunit, which includes the negative regulatory region previously believed to be essential for the functioning of Notch receptors, is partly or completely deleted. In addition, the synZTE is designed to bind orthogonal DNA target sequences in target organisms which in turn facilitates precise regulation of therapeutic gene expression with minimal off-target activity. Also provided are compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for treatment of various health conditions.
-
公开(公告)号:US20230174612A1
公开(公告)日:2023-06-08
申请号:US17995765
申请日:2021-03-24
发明人: Kole T. ROYBAL , Iowis ZHU , Raymond LIU , Ahmad S. KHALIL , Divya ISRANI
IPC分类号: C07K14/705 , C07K16/28 , A61K35/17 , C12N15/86
CPC分类号: C07K14/705 , C07K14/70517 , C07K16/2803 , A61K35/17 , C12N15/86 , C07K2319/81 , C07K2317/622 , C07K2319/03 , C07K2319/035 , C07K2317/24 , C07K2319/715 , C12N2740/15043
摘要: The present disclosure generally relates to, inter alia, a new class of chimeric Notch receptors containing a synthetic zinc finger transcriptional effector (synZTE) module, engineered to modulate gene expression and cellular activities in a ligand-dependent manner. The new Notch receptors surprisingly retain the ability to transduce signals in response to ligand binding despite that the Notch extracellular subunit (NEC), which includes the negative regulatory region (NRR) previously believed to be essential for the functioning of Notch receptors, is partly or completely deleted. In addition, the synZTE is designed to bind orthogonal DNA target sequences in target organisms which in turn facilitates precise regulation of therapeutic gene expression with minimal off-target activity. Also provided are compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for the treatment of various health conditions such as cancers.
-
公开(公告)号:US20220372101A1
公开(公告)日:2022-11-24
申请号:US17763110
申请日:2020-09-23
发明人: Kole T. ROYBAL , Raymond LIU , Iowis ZHU
IPC分类号: C07K14/705 , C07K14/47 , C07K16/28 , A61P35/02 , A61K35/17 , A61K45/06 , A61K39/395 , A61K38/17 , C07K14/575 , A61K38/22 , A61P35/00
摘要: The present disclosure generally relates to, among other things, a new class of receptors engineered to modulate transcription in a ligand-dependent manner. The new receptors provide a selectable degree of noise, expression level, and signal to noise ratio. The disclosure also provides compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for the treatment of various health conditions or diseases, such as cancers.
-
公开(公告)号:US20220340637A1
公开(公告)日:2022-10-27
申请号:US17762685
申请日:2020-09-23
发明人: Kole T. ROYBAL , Raymond LIU , Iowis ZHU
IPC分类号: C07K14/705 , C07K16/28 , A61K35/17 , A61P35/02 , A61K45/06 , A61K39/395 , A61K38/17
摘要: The present disclosure generally relates to, inter alia, a new class of receptors engineered to modulate transcriptional regulation in a ligand-dependent manner. Particularly, the new receptors, even though derived from Notch, do not require the Notch negative regulatory regions previously believed to be essential for the functioning of the receptors. In addition, the new receptors described herein incorporate a flexible polypeptide connector region disposed between the extracellular ligand-binding domain (ECD) and the transmembrane domain (TMD) which facilitates optimizing the stiffness/flexibility of the chimeric polypeptides to achieve a desired activity. The disclosure also provides compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for the treatment of various health conditions such as diseases (e.g., cancers).
-
公开(公告)号:US20230183709A1
公开(公告)日:2023-06-15
申请号:US17995751
申请日:2021-04-08
发明人: Kole T. ROYBAL , Raymond LIU
IPC分类号: C12N15/113 , C07K14/705 , C07K16/28 , C12N15/86
CPC分类号: C12N15/1138 , C07K14/705 , C07K16/2803 , C07K16/2878 , C12N15/86 , A61K2039/505
摘要: The present disclosure generally relates to, inter alia, a new class of chimeric Notch receptors containing a fully humanized transcriptional effector, engineered to modulate gene expression and cellular activities in a ligand-dependent manner. The new chimeric Notch receptors surprisingly retain the ability to transduce signals in response to ligand binding despite that the Notch extracellular subunit (NEC), which includes the negative regulatory region (NRR) previously believed to be essential for the functioning of Notch receptors is completely absent. In addition, the new receptors described herein incorporate an extracellular oligomerization domain to promote oligomer formation of the chimeric receptors. Also provided are compositions and methods useful for producing such receptors, nucleic acids encoding same, engineered cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for the treatment of various diseases such as cancers.
-
6.
公开(公告)号:US20220348628A1
公开(公告)日:2022-11-03
申请号:US17762687
申请日:2020-09-23
发明人: Kole T. ROYBAL , Raymond LIU , Iowis ZHU
摘要: The present disclosure generally relates to, among other things, a new class of receptors engineered to modulate transcriptional regulation in a ligand-dependent manner Particularly, the new receptors, even though derived from Notch and Robo, do not require the Notch or Robo regulatory regions previously believed to be necessary for the functioning of the receptors. The disclosure also provides compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for the treatment of various health conditions such as diseases (e.g., cancers).
-
公开(公告)号:US20210268024A1
公开(公告)日:2021-09-02
申请号:US17217618
申请日:2021-03-30
发明人: Kole T. ROYBAL , Raymond Liu , Iowis Zhu
IPC分类号: A61K35/17 , A61P35/00 , C07K16/28 , C07K14/705 , C07K16/32
摘要: The present disclosure generally relates to, inter alia, a new class of receptors engineered to modulate transcriptional regulation in a ligand-dependent manner. Particularly, the new receptors, even though derived from Notch, do not require the Notch negative regulatory regions previously believed to be essential for the functioning of the receptors. In addition, the new receptors described herein incorporate an extracellular oligomerization domain to promote oligomer formation of the chimeric receptors. The disclosure also provides compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for the treatment of various health conditions such as cancers.
-
公开(公告)号:US20210206826A1
公开(公告)日:2021-07-08
申请号:US15777592
申请日:2016-11-17
IPC分类号: C07K14/725 , C12N15/86
摘要: The present disclosure provides heteromeric, conditionally repressible synthetic immune cell receptors, nucleic acids expressing such receptors, cells expressing such nucleic acids and methods of making and using such receptors and nucleic acids. The present disclosure also provides methods of repressing immune cell activation attributable to a stimulatory synthetic immune cell receptor by dimerizing the stimulatory synthetic immune cell receptor with a synthetic immune cell repressor.
-
公开(公告)号:US20240301403A1
公开(公告)日:2024-09-12
申请号:US18263366
申请日:2022-01-28
发明人: Daniel B. GOODMAN , Camillia S. AZIMI , Kole T. ROYBAL , Jeffrey A. BLUESTONE , Alexander MARSON
CPC分类号: C12N15/1093 , C12N15/86 , C12N2750/14143
摘要: This disclosure generally relates to high-throughput and modular methods and compositions for barcode-trackable cellular receptor design, manufacture, and measurement.
-
10.
公开(公告)号:US20240181057A1
公开(公告)日:2024-06-06
申请号:US18552141
申请日:2022-03-22
发明人: Kole T. ROYBAL , Iowis ZHU , Raymond LIU
IPC分类号: A61K39/00 , A61K38/00 , A61K45/06 , A61K48/00 , C07K14/47 , C07K14/485 , C07K14/705 , C07K14/715 , C07K16/28 , C07K16/30 , C07K16/32 , C07K16/40 , C12N5/0783 , C12N9/16
CPC分类号: A61K39/464482 , A61K39/4611 , A61K39/4612 , A61K39/4633 , A61K39/464404 , A61K39/464406 , A61K39/464412 , A61K39/464466 , A61K39/46447 , A61K45/06 , A61K48/0058 , C07K14/47 , C07K14/4707 , C07K14/485 , C07K14/705 , C07K14/70503 , C07K14/70517 , C07K14/7153 , C07K16/2803 , C07K16/2863 , C07K16/2878 , C07K16/2887 , C07K16/3007 , C07K16/3092 , C07K16/32 , C07K16/40 , C12N5/0636 , C12N9/16 , C12Y301/03048 , A61K38/00 , A61K39/00 , C07K2317/24 , C07K2317/622 , C07K2319/02 , C07K2319/03 , C07K2319/09 , C07K2319/30 , C07K2319/50 , C07K2319/71 , C12N2510/00
摘要: The present disclosure generally relates to, among other things, a new class of receptors engineered to modulate transcriptional regulation in a ligand-dependent manner. In particular, the new receptors contain a heterologous stop-transfer-sequence and a γ-secretase cleavable transmembrane domain. The disclosure also provides compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating an activity of a cell and/or for the treatment of various diseases such as cancers.
-
-
-
-
-
-
-
-
-